This Article Full Text Full Text (PDF) All Versions of this Article: 93/8/3029    most recent Author Manuscript (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Google Scholar Articles by Misra, M. Articles by Klibanski, A. PubMed PubMed Citation Articles by Misra, M. Articles by Klibanski, A. Related Collections Pediatric Endocrinology Calcium and Bone Metabolism Male Endocrinology

Bone Metabolism in Adolescent Boys with Anorexia Nervosa

Neuroendocrine Unit (M.M., J.C., N.M., K.K.M., A.K.) and Harris Center (D.B.H.), Massachusetts General Hospital and Harvard Medical School, and Pediatric Endocrine Unit (M.M.), Massachusetts General Hospital for Children and Harvard Medical School, Boston, Massachusetts 02114; and Division of Adolescent Medicine (D.K.K., S.J.M.), Children, Toronto, Ontario, Canada M5G 1X8

Address all correspondence and requests for reprints to: Madhusmita Misra, M.D., BUL 457, Neuroendocrine Unit, Massachusetts General Hospital, 55 Fruit Street, Boston, Massachusetts 02114. E-mail: mmisra{at}partners.org.

Background: Anorexia nervosa (AN) is a condition of severe undernutrition associated with low bone mineral density (BMD) in adolescent females with this disorder. Although primarily a disease in females, AN is increasingly being recognized in males. However, there are few or no data regarding BMD, bone turnover markers or their predictors in adolescent AN boys.

Hypotheses: We hypothesized that BMD would be low in adolescent boys with AN compared with controls associated with a decrease in bone turnover markers, and that the gonadal steroids, testosterone and estradiol, and levels of IGF-I and the appetite regulatory hormones leptin, ghrelin, and peptide YY would predict BMD and bone turnover markers.

Methods: We assessed BMD using dual-energy x-ray absorptiometry and measured fasting testosterone, estradiol, IGF-I, leptin, ghrelin, and peptide YY and a bone formation (aminoterminal propeptide of type 1 procollagen) and bone resorption (N-telopeptide of type 1 collagen) marker in 17 AN boys and 17 controls 12–19 yr old.

Results: Boys with AN had lower BMD and corresponding Z-scores at the spine, hip, femoral neck, trochanter, intertrochanteric region, and whole body, compared with controls. Height-adjusted measures (lumbar bone mineral apparent density and whole body bone mineral content/height) were also lower. Bone formation and resorption markers were reduced in AN, indicating decreased bone turnover. Testosterone and lean mass predicted BMD. IGF-I was an important predictor of bone turnover markers.

Conclusion: AN boys have low BMD at multiple sites associated with decreased bone turnover markers at a time when bone mass accrual is critical for attainment of peak bone mass.

This article has been cited by other articles:

				M. A. Goldstein, D. B. Herzog, M. Misra, and P. Sagar Case 29-2008 -- A 19-Year-Old Man with Weight Loss and Abdominal Pain N. Engl. J. Med., September 18, 2008; 359(12): 1272 - 1283. [Full Text] [PDF]